PXD005407 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | Tumor suppressor TAp73 is required to maintain pluripotency of cancer stem cells |
Description | Cancer stem cells (CSCs) are resistant to conventional chemotherapy and are hence responsible for cancer relapse. Pluripotency is a characteristic of CSCs which allows them to rapidly proliferate while maintaining the ability to differentiate into various lineages. We found that TAp73, but not its homologue p53, is required for the pluripotency of CSCs. TAp73 knockdown (KD) decreased SOD1 levels, increased ROS production and disturbed metabolism which induced differentiation and abrogated pluripotency in CSCs. TAp73 related decrease in pluripotency is linked to increased autophagy and senescence in CSCs. Furthermore, TAp73 KD also decreased the levels of pluripotency factor Sox-2 within heterogeneous cancer cell lines. Interestingly, TAp73-deficient CSCs strongly lose tumorigenic potential in mice and tumors that did form had significantly lower levels of SOD1 and pluripotency marker Oct4. Our findings reveal a unique role of TAp73 in CSCs development that is important to consider while devising future therapeutic strategies against cancer. |
HostingRepository | PRIDE |
AnnounceDate | 2019-03-05 |
AnnouncementXML | Submission_2019-03-05_04:07:11.xml |
DigitalObjectIdentifier | https://dx.doi.org/10.6019/PXD005407 |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Supported dataset by repository |
PrimarySubmitter | Patrick Murphy |
SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
ModificationList | TMT6plex; Oxidation; Carbamidomethyl |
Instrument | Orbitrap Fusion |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2016-11-21 04:28:38 | ID requested | |
⏵ 1 | 2019-03-05 04:07:12 | announced | |
Publication List
Sharif T, Dai C, Martell E, Ghassemi-Rad MS, Hanes MR, Murphy PJ, Kennedy BE, Venugopal C, Subapanditha M, Giacomantonio CA, Marcato P, Singh SK, Gujar S, TAp73 Modifies Metabolism and Positively Regulates Growth of Cancer Stem-Like Cells in a Redox-Sensitive Manner. Clin Cancer Res, 25(6):2001-2017(2019) [pubmed] |
Keyword List
curator keyword: Biological, Biomedical |
submitter keyword: Stem Cells, p73 |
Contact List
Dr. Shashi Gujar |
contact affiliation | Departments of Pathology, Microbiology and Immunology, Dalhousie University |
contact email | shashi.gujar@dal.ca |
lab head | |
Patrick Murphy |
contact affiliation | Mass Spectrometry |
contact email | pitter9@gmail.com |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/03/PXD005407 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD005407
- Label: PRIDE project
- Name: Tumor suppressor TAp73 is required to maintain pluripotency of cancer stem cells